0000000000480892

AUTHOR

Bruce E. Johnson

showing 1 related works from this author

C1-02: Randomized Phase II study of vandetanib alone or in combination with carboplatin and paclitaxel as 1st-line treatment for advanced NSCLC

2007

Pulmonary and Respiratory MedicineOncologymedicine.medical_specialtybusiness.industryPhases of clinical researchVandetanibCarboplatinchemistry.chemical_compoundOncologyPaclitaxelchemistryInternal medicinemedicineLine (text file)businessmedicine.drugJournal of Thoracic Oncology
researchProduct